However, mitochondrial inhibition (via metformin) of p53 (−/−) colon cancer xenografts selectively leads to significant growth suppression, demonstrating that increased glycolysis alone does not explain the unchecked pattern of tumor proliferation [88]. Here, TP53 is linked to neoplasm.